Kemadrin Related Published Studies
Well-designed clinical trials related to Kemadrin (Procyclidine)
Effects of acute procyclidine administration on prepulse inhibition of the startle response in schizophrenia: a double-blind, placebo-controlled study. [2003.03]
Effects of 10 mg and 15 mg oral procyclidine on critical flicker fusion threshold and cardiac functioning in healthy human subjects. [2002.06]
Effects of procyclidine on prepulse inhibition of the acoustic startle response in healthy human volunteers. [2001.03]
Well-designed clinical trials possibly related to Kemadrin (Procyclidine)
Carbamazepine compared to haloperidol in acute mania. [1989.07]
A pilot study of the role of prophylactic antiparkinson treatment during neuroleptic therapy. [1989.05]
Other research related to Kemadrin (Procyclidine)
Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs. [2005.11.21]
Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats. [2004.11.28]
Effects of procyclidine on eye movements in schizophrenia. [2003.12]
Anti-parkinsonian agents procyclidine and ethopropazine alleviate thermal hyperalgesia in neuropathic rats. [2003.05]
Nasal absorption of procyclidine in rats and dogs. [2001.06]
Paradoxical autonomic response to procyclidine in the neuroleptic malignant syndrome. [1995.08]
Other possibly related research studies
Abdominal pain with rigidity secondary to the anti-emetic drug metoclopramide. [2006.05]
Efficacy of immediate and subsequent therapies against soman-induced seizures and lethality in rats. [2006.02]
Lack of association between prepulse inhibition and antisaccadic deficits in chronic schizophrenia: implications for identification of schizophrenia endophenotypes. [2005.05]
Protection against soman-induced seizures in rats: relationship among doses of prophylactics, soman, and adjuncts. [2004.05.01]
Probable dystonic reaction after a single dose of cyclizine in a patient with a history of encephalitis. [2003.03]
[Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs] [2002.11]
Lessons to be learned: a case study approach. 'Spontaneous' intraperitoneal bladder rupture in a psychiatric patient--with diagnostic difficulties. [2001.06]
Neuroleptic malignant syndrome associated with abrupt withdrawal of anticholinergic agents. [1996.09]
Antipsychotic drug-induced dysphoria. [1995.10]
Acute dystonic drug reaction or tetanus? An unusual consequence of a 'Whizz' overdose. [1994.05]
Acute dystonic reactions complicated by psychotic phenomena. [1994.01]
Excessive use of anticholinergic drugs in a sub-sample of Italian schizophrenics. [1991.05]
Urinary retention--an unusual dystonic reaction to continuous metoclopramide infusion. [1991.05]
Betel nut-induced extrapyramidal syndrome: an unusual drug interaction. [1989]
Muscle pathology in the neuroleptic malignant syndrome. [1987.12]
Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics. [1987.11]
Pharmacological agents, hippocampal EEG, and anticonvulsant effects on soman-induced seizures in rats. [2003.06]
Variable effects of previously untested muscarinic receptor antagonists on experimental myopia. [2003.03]
Combination anticonvulsant treatment of soman-induced seizures. [2001.12]
Anticholinergic drugs used in Parkinson's disease: An overlooked class of drugs from a pharmacokinetic perspective. [1999.05]
Anticholinergic medication for neuroleptic-induced tardive dyskinesia. [2000]
[Fatalities caused by anticholinergic antiparkinsonian drugs. Analysis of findings in a 11-year national material] [1998.01.10]
Administration of PRN medication by mental health nurses. [1996.11.28]
Excitatory amino acid antagonists and the anticonvulsive activity of conventional antiepileptic drugs. [1995.05]
Recurrent neuroleptic malignant syndrome in a man with mild mental handicap. [1992.08]
Muscarinic receptor subclassification and G-proteins: significance for lithium action in affective disorders and for the treatment of the extrapyramidal side effects of neuroleptics. [1989.06]
Anticonvulsant efficacy of drugs with cholinergic and/or glutamatergic antagonism microinfused into area tempestas of rats exposed to soman. [2008.02]
Antiparkinson drugs used as prophylactics for nerve agents: studies of cognitive side effects in rats. [2008.06]
Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. [2008.10]
Stuttering priapism--a review of the therapeutic options. [2008.08]
Identification of neuronal target areas for nerve agents and specification of receptors for pharmacological treatment. [2010.07.17]
The use of organotypic hippocampal slice cultures to evaluate protection by non-competitive NMDA receptor antagonists against excitotoxicity. [2010.03]
Roles of perirhinal and posterior piriform cortices in control and generation of seizures: a microinfusion study in rats exposed to soman. [2010.01]
Fatalities associated with clozapine-related constipation and bowel obstruction: a literature review and two case reports. [2009.07]
Non-enzymatic pretreatment of nerve agent (soman) poisoning: a brief state-of-the-art review. [2011.09.25]
Identification of neuronal target areas for nerve agents and specification of receptors for pharmacological treatment. [2010.12]
|
